Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
compare the efficacy and safety of two different formulations of insulin degludec (IDeg) in
subjects with type 2 diabetes.